♦Interferon-beta-1a



♦Interferon-beta-1a





(in-ter-feer’-on)

Avonex

Pregnancy Category C


Mechanism of Action

Not clearly understood; exerts biologic activities by binding to cell surface receptors.


Indications

To decrease physical disability and reduce the frequency of clinical exacerbations in relapsing forms of multiple sclerosis.


Metabolism/Excretion

After IM injection, serum levels peak between 3 and 15 hours with an elimination half-life of 10 hours. After SQ injection, serum levels peak between 3 to 18 hours with an elimination half-life of 8.6 hours.


Dosage Range

♦ Adult: 30 mcg injected IM once a week.

♦ Pediatric: Safety and efficacy not established.

Jul 20, 2016 | Posted by in ONCOLOGY | Comments Off on ♦Interferon-beta-1a

Full access? Get Clinical Tree

Get Clinical Tree app for offline access